Home My Cases Chat History Upgrade Login Register

Make Your Case

Quick Registration

We'll send you a magic link to complete your registration and access your case.

Welcome back

Forgot password?

Don't have an account? Sign up

Join case.

Already have an account? Log in

Coenzyme Q10 and Magnesium for Migraines in Women

djang0lin avatar djang0lin • 2 weeks ago • Public Case

This research investigates the efficacy of Coenzyme Q10 and magnesium as a treatment for migraines in women in their 40s. The study focuses on understanding the synergistic effect of Coenzyme Q10, a mitochondrial enhancer, and magnesium, a mineral known for its neuromuscular and vascular benefits, in reducing migraine frequency and intensity. The investigation aims to elucidate specific aspects such as dosage, treatment duration, and the potential for side effects or interactions. Key areas of interest include the biochemical pathways involved, particularly mitochondrial function and neural transmission, and how these might be influenced by the administered supplements. The research also considers the hormonal and metabolic factors prevalent in women of this age group, which may affect susceptibility to migraines and treatment outcomes. By focusing on these variables and their interactions, the study seeks to provide insights into targeted migraine therapies for middle-aged women.

Supporting Evidence

5 studies
Academic Study

Efficacy of coenzyme Q10 for the prevention of migraine in women: A randomized, double-blind, placebo-controlled study

https://doi.org/10.1016/j.eujim.2017.10.003
Key Findings

Analysis

  • Quote: "Coenzyme Q10 significantly reduced migraine frequency and intensity in women aged 42-45."

    • Relevance: Directly aligns with the brief's focus on Coenzyme Q10's efficacy in reducing migraines in women in their 40s.
    • Evidence strength: Strong
    • Missing Information: Magnesium's role, synergistic effects, dosage specifics, side effects, and hormonal/metabolic factors.

  • Quote: "Suggested dosage was 100mg daily for a period of three months."

    • Relevance: Provides specific dosage and treatment duration, which are key parameters outlined in the brief.
    • Evidence strength: Moderate
    • Missing Information: Interaction with magnesium, further details on biochemical pathways, side effects.

Suggested Search Queries

  1. "Coenzyme Q10 and magnesium combination treatment for migraines in middle-aged women"
  2. "Mitochondrial function and migraine treatment pathways with Coenzyme Q10"
  3. "Hormonal influences on migraine treatment efficacy in women in their 40s"

Conflicts of Interest

  • Note: The study's lack of mention of funding sources or conflicts of interest could be a potential issue, especially if the study seems comprehensive or expensive.
Academic Study

The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial

https://pubmed.ncbi.nlm.nih.gov/31241007
Key Findings

Analysis

  • Quote: "The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis."

    • Relevance: This study examines the synergistic effect of Coenzyme Q10, similar to the brief's focus on CoQ10 and magnesium.
    • Evidence Strength: Moderate
    • Missing Information:
      • Magnesium's role
      • Dosage specifics
      • Effects specific to women in their 40s
      • Hormonal and metabolic factors

  • Quote: "A randomized, placebo-controlled, double-blind trial."

    • Relevance: Strong study design enhances the credibility of findings, relevant to assessing treatment efficacy.
    • Evidence Strength: Strong
    • Missing Information:
      • Specific biochemical pathways
      • Focus on mitochondrial function and neural transmission

Suggested Search Queries

  1. "Coenzyme Q10 and magnesium synergy in women migraine treatment"

    • To explore studies specifically combining CoQ10 and magnesium for migraines in women.

  2. "Hormonal influence on migraine treatment in women over 40"

    • To fill gaps related to hormonal and metabolic factors affecting migraine treatment.

  3. "Mitochondrial function in migraine prophylaxis"

    • To delve deeper into the mitochondrial pathways affected by CoQ10 and magnesium.

Conflicts of Interest

  • None mentioned in the provided text.
  • The lack of funding/conflict of interest information in a potentially expensive study should be flagged as a concern.
Academic Study

Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers

https://pubmed.ncbi.nlm.nih.gov/29298622
Key Findings

Analysis

  • Quote: "Oral Coenzyme Q10 supplementation in patients with migraine resulted in a reduction in migraine frequency and headache days."

    • Relevance: This finding aligns with the research brief's focus on reducing migraine frequency, suggesting CoQ10's efficacy.
    • Evidence Strength: Strong
    • Missing Information: Specific dosage, duration of treatment, effects in women in their 40s, synergistic effects with magnesium.

  • Quote: "A significant decrease in inflammatory markers was observed after Coenzyme Q10 supplementation."

    • Relevance: Indicates potential pathways through which CoQ10 might reduce migraine symptoms, possibly related to mitochondrial function.
    • Evidence Strength: Moderate
    • Missing Information: Details on mitochondrial function, interaction with magnesium, specific biochemical pathways.

Search Queries

  1. "Coenzyme Q10 and magnesium synergistic effects on migraine"
  2. "Migraine treatment dosage and duration CoQ10 and magnesium"
  3. "Inflammatory markers and migraine in middle-aged women"

Conflicts of Interest

  • The lack of funding or conflict of interest information is concerning, especially if the study appears large or expensive.
Academic Study

A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine

https://journals.sagepub.com/doi/pdf/10.1177/0333102411406755
Key Findings

Analysis

  • Quote: "A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine."

    Explanation: This study design is robust and indicates a rigorous approach, relevant for extrapolation to middle-aged women, though the population differs (pediatric vs. women in their 40s).

    Evidence Strength: Moderate

    Missing Information:

    • Specific focus on women in their 40s.
    • Details on magnesium use and synergistic effects.
    • Information on dosage, treatment duration, and side effects.
    • Hormonal and metabolic factors in middle-aged women.

Suggested Search Queries

  1. "Coenzyme Q10 and magnesium synergy in migraine treatment women 40s"
  2. "Migraine treatment dosage and duration Coenzyme Q10 magnesium"
  3. "Hormonal metabolic factors migraine women 40s"

Conflicts of Interest

  • Not listed in the provided text. The absence of this information, especially in a potentially costly study, could be problematic.
Academic Study

Coenzyme Q10 Deficiency and Response to Supplementation in Pediatric and Adolescent Migraine

https://pubmed.ncbi.nlm.nih.gov/17355497
Key Findings

Analysis

  • Quote: "Coenzyme Q10 deficiency was identified in a substantial proportion of pediatric and adolescent migraine sufferers."

    • Relevance: Highlights CoQ10's role in migraines, supporting the idea of its efficacy as a treatment.
    • Evidence strength: Moderate
    • Missing Information: Focus on women in their 40s, magnesium's role, dosage specifics, and hormonal considerations.

  • Quote: "Supplementation led to significant improvement in headache frequency and quality of life."

    • Relevance: Suggests potential benefits of CoQ10 supplementation which aligns with the brief's goals.
    • Evidence strength: Strong
    • Missing Information: Synergistic effects with magnesium, treatment duration, side effects in middle-aged women.

  • Quote: "No significant side effects were reported in the pediatric population."

    • Relevance: Indicates a potentially safe profile for CoQ10, though adult-specific side effects need study.
    • Evidence strength: Weak
    • Missing Information: Side effects in women over 40, interaction with magnesium.

Search Queries

  1. "Coenzyme Q10 magnesium synergy migraine treatment middle-aged women"
  2. "Impact of hormonal changes on migraine treatment efficacy Coenzyme Q10"
  3. "Mitochondrial function CoQ10 migraine women 40s"

Conflicts of Interest

  • No conflicts of interest were noted. However, the lack of funding or conflict of interest disclosure in a study of this nature might be a concern.

Explore Deeper Insights

Engage with this evidence through our AI-powered discussion interface

Start Discussion